| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Glycyrrhizic Acid | Acute Liver Injury | 2 | PM | 35237151 | 📋 | Transcriptome and Lipid Metabolomics-Based Discovery: Glycyrrhizic Acid Alleviates Tripterygium Glycoside Tablet-Induced Acute Liver Injury by Regulating the Activities of CYP and the Metabolism of Phosphoglycerides |
| Glycyrrhizic Acid | Acute Liver Injury | 1 | PM | 32633407 | 📋 | Glycyrrhizin improves inflammation and apoptosis via suppressing HMGB1 and PI3K/mTOR pathway in lipopolysaccharide-induced acute liver injury |
| Glycyrrhizic Acid | Acute Liver Injury | 3 | PM | 23771023 | 📋 | Glycyrrhizin represses total parenteral nutrition-associated acute liver injury in rats by suppressing endoplasmic reticulum stress |
| Glycyrrhizic Acid | Acute Pancreatitis | 2 | PM | 38753240 | 📋 | Glycyrrhizin Ameliorates Cardiac Injury in Rats with Severe Acute Pancreatitis by Inhibiting Ferroptosis via the Keap1/Nrf2/HO-1 Pathway |
| Glycyrrhizic Acid | Acute Pancreatitis | 1 | PM | 38280993 | 📋 | Network pharmacology and in vitro experimental verification unveil glycyrrhizin from glycyrrhiza glabra alleviates acute pancreatitis via modulation of MAPK and STAT3 signaling pathways |
| Glycyrrhizic Acid | Autoimmune Hepatitis | 1 | PM | 36655685 | 📋 | Efficacy and Safety of Glycyrrhizic Acid in Treatment of Autoimmune Hepatitis |
| Glycyrrhizic Acid | Colitis | 1 | PM | 28108937 | 📋 | Glycyrrhizin ameliorates experimental colitis through attenuating interleukin-17-producing T cell responses via regulating antigen-presenting cells |
| Glycyrrhizic Acid | Colorectal Cancer | 1 | PM | 34747319 | 📋 | Glycyrrhizic acid exhibits strong anticancer activity in colorectal cancer cells via SIRT3 inhibition |
| Glycyrrhizic Acid | Colorectal Cancer | 2 | PM | 33807620 | 📋 | Glycyrrhizin Attenuates Carcinogenesis by Inhibiting the Inflammatory Response in a Murine Model of Colorectal Cancer |
| Glycyrrhizic Acid | Gastric Cancer | 1 | PM | 32425599 | 📋 | Glycyrrhizic Acid Inhibits Proliferation of Gastric Cancer Cells by Inducing Cell Cycle Arrest and Apoptosis |
| Glycyrrhizic Acid | Gastric Cancer | 2 | PM | 16012754 | 📋 | Glycyrrhizin induces apoptosis in human stomach cancer KATO III and human promyelotic leukemia HL-60 cells |
| Glycyrrhizic Acid | Helicobacter Pylori Infection | 1 | PM | 37038107 | 📋 | Glycyrrhizin, an inhibitor of HMGB1 induces autolysosomal degradation function and inhibits Helicobacter pylori infection |
| Glycyrrhizic Acid | Hepatic Cirrhosis | 1 | PM | 34299285 | 📋 | Glycyrrhizin Attenuates Portal Hypertension and Collateral Shunting via Inhibition of Extrahepatic Angiogenesis in Cirrhotic Rats |
| Glycyrrhizic Acid | Hepatic Fibrosis | 2 | PM | 36805480 | 📋 | Glycyrrhizic acid alleviates liver fibrosis in vitro and in vivo via activating CUGBP1-mediated IFN-γ/STAT1/Smad7 pathway |
| Glycyrrhizic Acid | Hepatic Fibrosis | 1 | PM | 27282665 | 📋 | Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation |
| Glycyrrhizic Acid | Hepatic Ischemia-Reperfusion | 1 | PM | 32963746 | 📋 | The protective effect of glycyrrhizin on hepatic ischemia-reperfusion injury in rats and possible related signal pathway |
| Glycyrrhizic Acid | Hepatic Ischemia-Reperfusion | 2 | PM | 30634142 | 📋 | Glycyrrhizin attenuates hepatic ischemia-reperfusion injury by suppressing HMGB1-dependent GSDMD-mediated kupffer cells pyroptosis |
| Glycyrrhizic Acid | Hepatitis | 2 | PM | 30553196 | 📋 | Glycyrrhizin alleviates Con A-induced hepatitis by differentially regulating the production of IL-17 and IL-25 |
| Glycyrrhizic Acid | Hepatitis A | 1 | PM | 8141593 | 📋 | Studies on mechanism of action of glycyrrhizin against hepatitis A virus replication in vitro |
| Glycyrrhizic Acid | Hepatitis B | 1 | PM | 7814808 | 📋 | Effects of glycyrrhizin on hepatitis B surface antigen: a biochemical and morphological study |
| Glycyrrhizic Acid | Hepatitis C | 1 | PM | 21762538 | 📋 | Glycyrrhizin as antiviral agent against Hepatitis C Virus |
| Glycyrrhizic Acid | Hepatitis C | 2 | PM | 21382166 | 📋 | A glycyrrhizin-containing preparation reduces hepatic steatosis induced by hepatitis C virus protein and iron in mice |
| Glycyrrhizic Acid | Hepatitis C | 3 | PM | 16082287 | 📋 | Treatment of Chronic Hepatitis C Virus Infection via Antioxidants: Results of a Phase I Clinical Trial |
| Glycyrrhizic Acid | Hepatitis C | 4 | PM | 11868794 | 📋 | Long-term treatment of chronic hepatitis C with glycyrrhizin [stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma |
| Glycyrrhizic Acid | Hepatitis C | 5 | PM | 9118029 | 📋 | The long term efficacy of glycyrrhizin in chronic hepatitis C patients |
| Glycyrrhizic Acid | Liver Cancer | 6 | PM | 38700384 | 📋 | Glycyrrhizic acid attenuates the malignant biological properties of nonalcoholic fatty liver disease-related hepatocellular carcinoma |
| Glycyrrhizic Acid | Liver Cancer | 5 | PM | 38426342 | 📋 | Glycyrrhizic acid attenuates sorafenib resistance by inducing ferroptosis via targeting mTOR signaling in hepatocellular carcinoma |
| Glycyrrhizic Acid | Liver Cancer | 4 | PM | 36193082 | 📋 | Identification of the Mechanism of Matrine Combined with Glycyrrhizin for Hepatocellular Carcinoma Treatment through Network Pharmacology and Bioinformatics Analysis |
| Glycyrrhizic Acid | Liver Cancer | 1 | PM | 31998631 | 📋 | Glycyrrhizic Acid-Induced Differentiation Repressed Stemness in Hepatocellular Carcinoma by Targeting c-Jun N-Terminal Kinase 1 |
| Glycyrrhizic Acid | Liver Cancer | 2 | PM | 11868794 | 📋 | Long-term treatment of chronic hepatitis C with glycyrrhizin [stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma |
| Glycyrrhizic Acid | Liver Cancer | 3 | PM | 9118029 | 📋 | The long term efficacy of glycyrrhizin in chronic hepatitis C patients |
| Glycyrrhizic Acid | Liver Damage | 2 | PM | 18022618 | 📋 | In vivo glycyrrhizin accelerates liver regeneration and rapidly lowers serum transaminase activities in 70% partially hepatectomized rats |
| Glycyrrhizic Acid | Liver Disease | 2 | PM | 38553799 | 📋 | Glycyrrhizin and the Related Preparations: An Inspiring Resource for the Treatment of Liver Diseases |
| Glycyrrhizic Acid | Liver Disease | 1 | PM | 24963489 | 📋 | Glycyrrhizic acid in the treatment of liver diseases: literature review |
| Glycyrrhizic Acid | MAFLD | 2 | PM | 36272466 | 📋 | Modulation of gut microbiota by glycyrrhizic acid may contribute to its anti-NAFLD effect in rats fed a high-fat diet |
| Glycyrrhizic Acid | MAFLD | 1 | PM | 28414056 | 📋 | Protective effects of glycyrrhizic acid against non-alcoholic fatty liver disease in mice |
| Glycyrrhizic Acid | Nasopharyngeal Cancer | 1 | PM | 32523355 | 📋 | Inhibition of HMGB1 Overcomes Resistance to Radiation and Chemotherapy in Nasopharyngeal Carcinoma |
| Glycyrrhizic Acid | Non-Alcoholic Steatohepatitis | 3 | PM | 38316247 | 📋 | Glycyrrhizic acid restores the downregulated hepatic ACE2 signaling in the attenuation of mouse steatohepatitis |
| Glycyrrhizic Acid | Non-Alcoholic Steatohepatitis | 2 | PM | 29959134 | 📋 | Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-Inflammation |
| Glycyrrhizic Acid | Non-Alcoholic Steatohepatitis | 1 | PM | 27487733 | 📋 | Protective effects of glycyrrhizic acid from edible botanical glycyrrhiza glabra against non-alcoholic steatohepatitis in mice |
| Glycyrrhizic Acid | Ulcerative Colitis | 1 | PM | 25560991 | 📋 | Modulation of PPARγ and TNFα by emu oil and glycyrrhizin in ulcerative colitis |
